Phase III Trial of Dalcetrapib: Discontinued Due to Lack of Efficacy

By Sweetlove Mel  

Pharmaceutical Medicine, Vol. 26, Iss. 4, 2012-08 ,pp. : 253-256

Adis International

Access to resources Recommend Favorite

Phase III ATENA Trial of Exemestane Discontinued

By Sweetlove Mel  

Pharmaceutical Medicine, Vol. 26, Iss. 1, 2012-02 ,pp. : 45-47

Adis International

Access to resources Recommend Favorite

Phase III Trial of Eprotirome: Discontinued for Safety Concerns

By Sweetlove Mel  

Pharmaceutical Medicine, Vol. 26, Iss. 3, 2012-06 ,pp. : 185-187

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline (GSK) has discontinued enrolment into its phase III trial of the HIV entry inhibitor, aplaviroc [GW 873140]

By  

Reactions Weekly, Vol. 1, Iss. 1076, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A Randomized, Placebo-Controlled, Double-Blind Phase III Trial Investigating the Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Using a Stringent Composite Endpoint

By William Hanke C.   Narins Rhoda S.   Brandt Fredric   Cohen Joel L.   Donofrio Lisa M.   Downie Jeanine   Heinz Moritz   Harrington Laura   McDaniel David H.   Nestor Mark   Schlessinger Joel   Schlöbe Andrea   Taub Amy   Weiss Robert A.  

Dermatologic Surgery, Vol. 39, Iss. 6, 2013-06 ,pp. : 891-899

Elsevier

Access to resources Recommend Favorite